Best Medical Billing Company in Massachusetts

Relevant billing support includes charge entry, coding review, claim scrubbing, submission, rejection clearing, denial management, authorization support, payment reconciliation, aging A/R follow-up, and revenue-cycle workflow review. Infectious disease practices may also need guidance for infusion, OPAT, buy-and-bill drug claims, hospital consults, and payer or coverage agreements. The right focus depends on the practice’s workflow and revenue streams.

Revenue leakage can occur through under-leveled visits, missed drug or administration charges, documentation gaps, incorrect units, authorization problems, contract issues, and unresolved balances. A structured review can trace the problem to documentation, charge capture, coding, payer rules, or follow-up. Reviewing trends by payer, service line, and provider helps practices identify recurring issues rather than addressing claims in isolation.

Yes. Infectious disease billing may involve office visits, hospital consults, infusion administration, drug claims, and OPAT services. Each service can have different documentation, authorization, benefit, coding, and reimbursement considerations. A useful revenue-cycle review follows the workflow from referral and first dose through final payment, helping the practice understand where clinical work and related charges may not be fully captured.

Some infectious disease therapies may be reviewed under a medical benefit, while others may fall under a pharmacy benefit. The applicable benefit can affect authorization steps, claim routing, documentation, and payment responsibility. Eligibility and benefit verification should identify the relevant coverage pathway before therapy begins, while authorization records should be tracked so the practice can address missing or mismatched requirements.

Denials can be categorized by root cause, such as drug and administration coding, missing authorization, medical-versus-pharmacy benefit confusion, under-documented consults, unit mismatches, or payer processing issues. Reviewing denial patterns by payer and service type helps reveal recurring workflow problems. Payer-specific appeals can then connect the clinical documentation and billing facts to the reason the claim was denied.

Payment reconciliation compares expected reimbursement with actual payments for drug, administration, and evaluation and management claims. The review can identify short-pays, incorrect fee schedule application, unit issues, NDC mismatches, or other differences requiring investigation. Tracking these findings by payer and claim type helps practices understand whether a payment issue is isolated or reflects a broader contract or billing pattern.

Yes. The resource hub is designed to help practices apply their own numbers rather than depend on generalized rates, costs, or margin assumptions. This supports more relevant evaluation of revenue streams, staffing decisions, operational choices, and financial sustainability. The tools are intended to clarify practice-specific mechanics while remaining explicit about figures that have not been licensed or verified.

GrowInfectiousDisease offers free, ungated resources and calculators focused on infectious disease practice economics. No email submission is required to receive a result, and calculator tools run in the browser without transmitting or storing user-entered data. The materials are intended for infectious disease physicians, independent practices, group leaders, and medical practice administrators evaluating operational and financial questions.